The European Mobile Laboratory, EMLab, was the first EBOV diagnostics unit deployed to the outbreak epicentre by WHO in March 2014.
Developing evidence-based guidelines for Kenyan children with indrawing pneumoniaby The Editorial Team
Tropical Medicine Global Health Video Seminar, University of Oxford
Watch the Malaria Consortium's excellent video summary of the amazing progress that has been made to address malaria, and also highlighing the key challenges that remain.
To highlight the Neglected Tropical Disease (NTD) Awareness Week, TWiGH brings to you a conversation with Amy Maxmen- who recently wrote a series on Mycetoma with Global Health Now.
Call for Papers: Special issue on strengthening tuberculosis diagnostic networks in Africa - African Journal of Laboratory Medicine
East African Leaders Join Together to Develop Country-Specific Plans for Point-of-Care Testing.
Using parasite population genetics to understand transmission dynamics in NTDsby The Editorial Team
Schistosomiasis, is a chronic, debilitating disease. Uganda began a National Control Programme in 2003 with annual MDA of praziquantel. MDA on this scale provides strong selective pressures on the parasite population with an associated risk of drug resistance developing.
In this video, Professor Theonest Mutabingwa discusses the two key challenges that face developing countries to progress their malaria research.
In this video of a seminar delivered at the University of Oxford in June 2014, Professor Nicholas White talks about the challenge of antimalarial resistance.
Anders Björkman is Professor of Infectious Disease at the Karolinska Institute. In this video, Anders talks about how the efficacy of antimalarials is a major obstacle in the path towards full malaria elimination.
In this seminar Professor Kevin Marsh describes how knowledge of immunity to malaria in humans has developed over the past thirty years and what impact this has for future research.
In celebration of Global Health Trials' fifth birthday (May 11th 2015) Professor Trudie Lang, Principal Investigator of the programme, talks to us about why Global Health Trials was started, why people should share their experience, and what the future holds.
ABRAID – The Atlas of Baseline Risk Assessment for Infectious Diseases - Call for feedbackby Dr Catherine Moyes
ABRAID, new website of infectious diseases risk maps
A Stronger Post-Publication Culture Is Needed for Better Scienceby Hilda Bastian
The Ebola virus epidemic may well spread out of Africa. Dr Greg Martin takes a look at some of the variables that contribute to this risk and discusses some steps that should be taken.
New publication on rifampicin Mono-Resistance in TBby Yacoob Mahomed Coovadia, Sharana Mahomed, Melendhran Pillay, Lise Werner, Koleka Mlisana
Clinical Research Laboratories for Trials in Global Health in Central Africaby ALI Innocent, akindeh, Prof Wilfred F. Mbacham
The authors present the story of building a succesful research laboratory in Cameroon, including how they managed building up the infrastructure, equipment maintenance, staff training.